Request for Information for the Development of the Fiscal Year 2019 Trans-NIH Plan for HIV-Related Research, 15526 [2017-06183]
Download as PDF
15526
Federal Register / Vol. 82, No. 59 / Wednesday, March 29, 2017 / Notices
Date: April 21, 2017.
Time: 9:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
Contact Person: Xiang-Ning Li, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112,
MSC 7854, Bethesda, MD 20892, 301–435–
1744, lixiang@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 23, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06147 Filed 3–28–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information for the
Development of the Fiscal Year 2019
Trans-NIH Plan for HIV-Related
Research
Through this Request for
Information (RFI), the Office of AIDS
Research (OAR) in the Division of
Program Coordination, Planning, and
Strategic Initiatives (DPCPSI), National
Institutes of Health (NIH), invites
feedback from investigators in
academia, industry, health care
professionals, patient advocates and
health advocacy organizations, scientific
or professional organizations, federal
agencies, community, and other
interested constituents on the
development of the fiscal year (FY) 2019
Trans-NIH Plan for HIV-Related
Research (FY 2019 AIDS Research Plan).
This plan is designed to identify and
articulate future directions to maximize
the NIH’s investments in HIV/AIDS
research.
DATES: The OAR’s Request for
Information is open for public comment
for a period of 45 days. Comments must
be received by May 15, 2017 to ensure
consideration. After the public comment
period has closed, the comments
received by the OAR will be considered
in a timely manner for the development
of the FY2019 AIDS Research Plan.
ADDRESSES: Submissions may be
electronically sent to https://
grants.nih.gov/grants/rfi/rfi.cfm?ID=63
or, if needed, by mail to Paul Gaist,
Ph.D., M.P.H. Office of AIDS Research,
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:54 Mar 28, 2017
Jkt 241001
National Institutes of Health, Room
2E40, 5601 Fishers Lane, Rockville,
Maryland 20852.
FOR FURTHER INFORMATION CONTACT:
Questions about this request for
information should be directed to Paul
Gaist, Ph.D., M.P.H. Office of AIDS
Research, National Institutes of Health
Email: ODOARRFI19@nih.gov or if
needed, by mail to Room 2E40, 5601
Fishers Lane, Rockville, Maryland
20852.
This RFI is for planning purposes
only and should not be construed as a
solicitation for applications or
proposals, or as an obligation in any
way on the part of the United States
federal government. The federal
government will not pay for the
preparation of any information
submitted or for the government’s use.
Additionally, the government cannot
guarantee the confidentiality of the
information provided.
To access
and respond to the RFI, go to the
following Web address: https://grants.
nih.gov/grants/rfi/rfi.cfm?ID=63.
OAR oversees and coordinates the
conduct and support of all HIV/AIDS
research activities across the NIH
Institutes and Centers (ICs). The NIHsponsored HIV/AIDS research program
includes both extramural and
intramural research, buildings and
facilities, research training, program
evaluation, and supports a
comprehensive portfolio of research
representing a broad range of basic,
clinical, behavioral, social science, and
translational research on HIV/AIDS and
its associated coinfections and
comorbidities.
OAR plans and coordinates research
through the development of an annual
Trans-NIH Plan for HIV-Related
Research that articulates the overarching
HIV/AIDS research priorities and serves
as the framework for developing the
trans-NIH HIV/AIDS research budget.
This Plan provides information about
the NIH’s HIV/AIDS research priorities
to the scientific community, Congress,
community stakeholders, HIV-affected
communities, and the broad public at
large. The fiscal year 2018 Trans-NIH
Plan for HIV-Related Research was
recently distributed on the OAR Web
site: (https://www.oar.nih.gov/strategic_
plan/plan_18.asp).
New overarching priorities for HIV/
AIDS research were defined in the NIH
Director’s Statement of August 12, 2015
(https://grants.nih.gov/grants/guide/
notice-files/NOT-OD-15-137.html).
High Priority topics of research for
support include:
(1) Reducing the incidence of HIV/
AIDS;
(2) Developing the next generation of
HIV therapies;
(3) Identifying strategies towards a
cure;
(4) Improving the prevention and
treatment of HIV-associated
comorbidities, coinfections, and
complications; and
(5) Cross-cutting basic research,
behavioral and social science research,
health disparities, and training.
Dated: March 23, 2017.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
[FR Doc. 2017–06183 Filed 3–28–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Center for Advancing Translational
Sciences.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cures Acceleration
Network Review Board.
Date: May 4, 2017.
Time: 8:30 a.m. to 2:30 p.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
E:\FR\FM\29MRN1.SGM
29MRN1
Agencies
[Federal Register Volume 82, Number 59 (Wednesday, March 29, 2017)]
[Notices]
[Page 15526]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06183]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information for the Development of the Fiscal Year
2019 Trans-NIH Plan for HIV-Related Research
SUMMARY: Through this Request for Information (RFI), the Office of AIDS
Research (OAR) in the Division of Program Coordination, Planning, and
Strategic Initiatives (DPCPSI), National Institutes of Health (NIH),
invites feedback from investigators in academia, industry, health care
professionals, patient advocates and health advocacy organizations,
scientific or professional organizations, federal agencies, community,
and other interested constituents on the development of the fiscal year
(FY) 2019 Trans-NIH Plan for HIV-Related Research (FY 2019 AIDS
Research Plan). This plan is designed to identify and articulate future
directions to maximize the NIH's investments in HIV/AIDS research.
DATES: The OAR's Request for Information is open for public comment for
a period of 45 days. Comments must be received by May 15, 2017 to
ensure consideration. After the public comment period has closed, the
comments received by the OAR will be considered in a timely manner for
the development of the FY2019 AIDS Research Plan.
ADDRESSES: Submissions may be electronically sent to https://grants.nih.gov/grants/rfi/rfi.cfm?ID=63 or, if needed, by mail to Paul
Gaist, Ph.D., M.P.H. Office of AIDS Research, National Institutes of
Health, Room 2E40, 5601 Fishers Lane, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Questions about this request for
information should be directed to Paul Gaist, Ph.D., M.P.H. Office of
AIDS Research, National Institutes of Health Email: ODOARRFI19@nih.gov
or if needed, by mail to Room 2E40, 5601 Fishers Lane, Rockville,
Maryland 20852.
SUPPLEMENTARY INFORMATION: To access and respond to the RFI, go to the
following Web address: https://grants.nih.gov/grants/rfi/rfi.cfm?ID=63.
OAR oversees and coordinates the conduct and support of all HIV/
AIDS research activities across the NIH Institutes and Centers (ICs).
The NIH-sponsored HIV/AIDS research program includes both extramural
and intramural research, buildings and facilities, research training,
program evaluation, and supports a comprehensive portfolio of research
representing a broad range of basic, clinical, behavioral, social
science, and translational research on HIV/AIDS and its associated
coinfections and comorbidities.
OAR plans and coordinates research through the development of an
annual Trans-NIH Plan for HIV-Related Research that articulates the
overarching HIV/AIDS research priorities and serves as the framework
for developing the trans-NIH HIV/AIDS research budget. This Plan
provides information about the NIH's HIV/AIDS research priorities to
the scientific community, Congress, community stakeholders, HIV-
affected communities, and the broad public at large. The fiscal year
2018 Trans-NIH Plan for HIV-Related Research was recently distributed
on the OAR Web site: (https://www.oar.nih.gov/strategic_plan/plan_18.asp).
New overarching priorities for HIV/AIDS research were defined in
the NIH Director's Statement of August 12, 2015 (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html).
High Priority topics of research for support include:
(1) Reducing the incidence of HIV/AIDS;
(2) Developing the next generation of HIV therapies;
(3) Identifying strategies towards a cure;
(4) Improving the prevention and treatment of HIV-associated
comorbidities, coinfections, and complications; and
(5) Cross-cutting basic research, behavioral and social science
research, health disparities, and training.
This RFI is for planning purposes only and should not be construed
as a solicitation for applications or proposals, or as an obligation in
any way on the part of the United States federal government. The
federal government will not pay for the preparation of any information
submitted or for the government's use. Additionally, the government
cannot guarantee the confidentiality of the information provided.
Dated: March 23, 2017.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2017-06183 Filed 3-28-17; 8:45 am]
BILLING CODE 4140-01-P